| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000021009 |
| Receipt No. | R000024247 |
| Official scientific title of the study | Direct peroral cholangioscopic diagnosis of bile duct lesions by high definition ultraslim endoscopy combined with computed virtual chromoendoscopy using i-scan; a pilot study (with videos) |
| Date of disclosure of the study information | 2016/02/14 |
| Last modified on | 2016/04/23 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Direct peroral cholangioscopic diagnosis of bile duct lesions by high definition ultraslim endoscopy combined with computed virtual chromoendoscopy using i-scan; a pilot study (with videos) | |
| Title of the study (Brief title) | computed virtual chromoendoscopy using i-scan versus white light in the evaluation of biliary tract lesions | |
| Region |
|
|
| Condition | ||
| Condition | biliary polypoid and elevated lesions | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of direct POC alone and in conjunction with NBIori-scan for the diagnosis of biliary polypoid and elevated lesions. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Diagnostic efficacy of direct POC with NBI or i-scan in biliary polypoid and elevated lesions. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | DPOC with NBI | |
| Interventions/Control_2 | DPOC with i-scan | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Intraductal bile duct mucosal lesion
2. Bile duct diameter >8mm 3. A previous sphincteroplasty such as major endoscopic sphincterotomy and/or endoscopic papillary balloon dilatation during a prior ERCP. |
|||
| Key exclusion criteria | 1. a bleeding tendency (international
normalized ratio >1.5 or platelet count <50,000/mm3) 2. diffuse stricture of the distal CBD, evidence of pancreatic cancer or tumor at the ampulla of Vater 3. contraindications for endoscopic retrograde cholangiography |
|||
| Target sample size | 25 | |||
| Research contact person | |
| Name of lead principal investigator | Jong Ho Moon |
| Organization | SoonChunHyang University
School of Medicine |
| Division name | Digestive Disease Center and Research Institute, Department of Internal Medicine |
| Address | Digestive Disease Center and Research Institute, SoonChunHyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 420-767, Korea |
| TEL | +82-32-621-5094 |
| jhmoon@schmc.ac.kr | |
| Public contact | |
| Name of contact person | Yun Nah Lee |
| Organization | Department of Internal Medicine, Soon Chun Hyang University School of Medicine |
| Division name | Digestive Disease Center and Research Institute, Department of Internal Medicine |
| Address | Digestive Disease Center and Research Institute, SoonChunHyang University Bucheon Hospital, 170 Joma |
| TEL | +82-32-621-5094 |
| Homepage URL | |
| yunnah@schmc.ac.kr | |
| Sponsor | |
| Institute | SoonChunHyang University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | SoonChunHyang University |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024247 |